- Home
- HOG vs FOLD Comparison
HOG vs FOLD Comparison
Compare HOG & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOG
- FOLD
- Stock Information
- Founded
- HOG 1903
- FOLD 2002
- Country
- HOG United States
- FOLD United States
- Employees
- HOG N/A
- FOLD N/A
- Industry
- HOG Motor Vehicles
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- HOG Consumer Discretionary
- FOLD Health Care
- Exchange
- HOG Nasdaq
- FOLD Nasdaq
- Market Cap
- HOG 3.4B
- FOLD 2.9B
- IPO Year
- HOG N/A
- FOLD 2007
- Fundamental
- Price
- HOG $22.51
- FOLD $6.83
- Analyst Decision
- HOG Buy
- FOLD Strong Buy
- Analyst Count
- HOG 7
- FOLD 9
- Target Price
- HOG $32.00
- FOLD $17.00
- AVG Volume (30 Days)
- HOG 3.0M
- FOLD 3.9M
- Earning Date
- HOG 05-01-2025
- FOLD 05-08-2025
- Dividend Yield
- HOG 3.20%
- FOLD N/A
- EPS Growth
- HOG N/A
- FOLD N/A
- EPS
- HOG 3.44
- FOLD N/A
- Revenue
- HOG $5,186,802,000.00
- FOLD $528,294,999.00
- Revenue This Year
- HOG N/A
- FOLD $21.83
- Revenue Next Year
- HOG $4.58
- FOLD $22.16
- P/E Ratio
- HOG $6.54
- FOLD N/A
- Revenue Growth
- HOG N/A
- FOLD 32.29
- 52 Week Low
- HOG $20.45
- FOLD $6.20
- 52 Week High
- HOG $40.14
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- HOG 43.88
- FOLD 32.01
- Support Level
- HOG $21.50
- FOLD $6.20
- Resistance Level
- HOG $22.84
- FOLD $6.95
- Average True Range (ATR)
- HOG 1.73
- FOLD 0.43
- MACD
- HOG -0.09
- FOLD -0.04
- Stochastic Oscillator
- HOG 39.46
- FOLD 29.86
About HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring segments, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 38% of the heavyweight domestic market in 2023.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.